India, May 1 -- While reporting financial results for the first quarter on Thursday, drugmaker Eli Lilly and Co. (LLY) lowered its earnings and adjusted earnings guidance for the full-year 2025, while maintaining annual revenue outlook.
For fiscal 2025, Eli Lilly now projects earnings in a range of $20.17 to $21.67 per share and adjusted earnings in a range of $20.78 to $22.28 per share on revenues between $58.0 billion and $61.0 billion.
Previously, the company expected earnings in a range of $22.05 to $23.55 per share and adjusted earnings in a range of $22.50 to $24.00 per share on revenues between $58.0 billion and $61.0 billion.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
On average, analyst...